Ruffolo R R, Sauermelch C F, Willette R N
Division of Pharmacology, Smith Kline Beecham, p.l.c., King of Prussia, Pennsylvania.
Eur J Clin Pharmacol. 1990;38 Suppl 2:S112-4. doi: 10.1007/BF01409477.
The effects of labetalol and carvedilol on local cutaneous microvascular perfusion and calculated local cutaneous microvascular resistance were investigated in anesthetized rats at submaximal doses that produced equivalent reductions in blood pressure and heart rate. Labetalol decreased cutaneous perfusion (-25% +/- 3%) without significantly affecting cutaneous vascular resistance (-6% +/- 3%). In marked contrast, carvedilol dramatically increased cutaneous perfusion (+64% +/- 9%) and significantly reduced cutaneous vascular resistance (-57% +/- 3%). These results suggest that carvedilol and labetalol possess differences in the mechanisms by which they produce vasodilation in vivo.
在麻醉大鼠中,研究了拉贝洛尔和卡维地洛在产生等效血压和心率降低的亚最大剂量下,对局部皮肤微血管灌注和计算得出的局部皮肤微血管阻力的影响。拉贝洛尔降低了皮肤灌注(-25%±3%),而对皮肤血管阻力没有显著影响(-6%±3%)。与之形成显著对比的是,卡维地洛显著增加了皮肤灌注(+64%±9%),并显著降低了皮肤血管阻力(-57%±3%)。这些结果表明,拉贝洛尔和卡维地洛在体内产生血管舒张的机制上存在差异。